A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance.
Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,
and over the past six months, the industry has pulled back by 6.7%. This drop was discouraging since the S&P 500 held steady.
Looking for the S&P500 stocks that are experiencing notable gaps on Wednesday? Find out which stocks are gapping up and gapping down in the S&P500 index during today's session.
A company that generates cash isn’t automatically a winner.
Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Let’s dig into the relative performance of Abbott Laboratories (NYSE:ABT) and its peers as we unravel the now-completed Q4 medical devices & supplies - diversified earnings season.
CooperCompanies’s stock price has taken a beating over the past six months, shedding 24.6% of its value and falling to $80.68 per share. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, including CooperCompanies (NASDAQ:COO) and its peers.
Stocks surged Wednesday morning, with major indices poised to snap a two-day losing streak, as cooler-than-expected inflation reinforced expectations for Federal Reserve rate cuts in 2025.
Shares of medical device company CooperCompanies (NASDAQ:COO)
fell 8.1% in the pre-market session after the company reported weak fourth quarter results: revenue missed, which is never a good sign. EPS was in line while the company reiterated full-year sales guidance. Markets typically reward companies that beat and raise guidance. Overall, the results could have been better.
Stay informed about the performance of the S&P500 index in the middle of the day on Friday. Uncover the top gainers and losers in today's session for valuable insights.
Stay tuned for the market movements in the S&P500 index on Friday. Check out the gap up and gap down stocks in the S&P500 index during today's session.
Medical device company CooperCompanies (NASDAQ:COO) fell short of the market’s revenue expectations in Q4 CY2024 as sales rose 3.6% year on year to $964.7 million. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $4.12 billion at the midpoint. Its non-GAAP profit of $0.92 per share was in line with analysts’ consensus estimates.
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns -
over the past six months, healthcare stocks have collectively shed 1.7%. This performance is a noticeable divergence from the S&P 500’s 8.9% return.
Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top S&P500 gainers and losers in today's session.
